Work

Abstract 5593: A combination of HDAC inhibitor Entinostat (MS-275), All Trans Retinoic Acid (ATRA) and low dose Doxorubicin causes regression of established xenografts of triple negative breast cancer

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-5593

Authors: Nguyen K. Nguyen, Preethi Korangath, Gauri Sabnis, Angela Brodie, Peter Ordentlich, Vered Stearns, Saraswati Sukumar

Institutions: Johns Hopkins Medicine, University of Maryland, Baltimore, Syndax Pharmaceuticals (United States)

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2012979235

Cites:

Cited by: 2

Related to: 10